Last 12 months
Inside the activity.
0 purchase rows · 1 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 30, 2018 Filed Dec 18, 2020 23:05 UTC |
Hunter Robert GailDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 5,651 | $4.86 Strike: $4.86 | $27,463.86 |
DisclosureSEC source: 0001096906-20-000518 · form4.xml · derivative · entry 18 Hunter Robert Gail · CIK 0001298091 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,651 Underlying: Class A Common Stock · 5,651 shares Expires 2028-11-30 F16 · derivative.exercise_price: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock options paid on February 1, 2019, and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F16 · shares: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock options paid on February 1, 2019, and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F16 · price: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock options paid on February 1, 2019, and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F16 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock options paid on February 1, 2019, and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F16 · balance_after: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock options paid on February 1, 2019, and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. Read SEC document |
| November 30, 2018 Filed Dec 30, 2020 23:19 UTC |
Wilbur Norman GDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 1,131 | $4.86 Strike: $4.86 | $5,496.66 |
DisclosureSEC source: 0001096906-20-000574 · form4.xml · derivative · entry 9 Wilbur Norman G · CIK 0001298096 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,131 Underlying: Class A Common Stock · 1,131 shares Expires 2028-11-30 F8 · derivative.exercise_price: This option was granted on November 30, 2018 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F8 · shares: This option was granted on November 30, 2018 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F8 · price: This option was granted on November 30, 2018 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F8 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F8 · balance_after: This option was granted on November 30, 2018 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. Read SEC document |
| November 30, 2018 Filed Dec 30, 2020 23:19 UTC |
Wilbur Norman GDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 5,651 | $4.86 Strike: $4.86 | $27,463.86 |
DisclosureSEC source: 0001096906-20-000574 · form4.xml · derivative · entry 8 Wilbur Norman G · CIK 0001298096 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,651 Underlying: Class A Common Stock · 5,651 shares Expires 2028-11-30 F7 · derivative.exercise_price: This option was granted on November 30, 2018 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F7 · shares: This option was granted on November 30, 2018 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F7 · price: This option was granted on November 30, 2018 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F7 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F7 · balance_after: This option was granted on November 30, 2018 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. Read SEC document |
| November 30, 2018 Filed Dec 31, 2020 22:03 UTC Amendment |
QUIST SCOTT MDirector · Chairman of the Board/Pres/CEO · 10% owner
|
GrantEmployee Stock Option (right to buy) · Derivative | 79,104 | $5.34 Strike: $5.34 | $422,415.36 |
DisclosureSEC source: 0001096906-20-000581 · form4.xml · derivative · entry 6 QUIST SCOTT M · CIK 0001268844 · Director · Chairman of the Board/Pres/CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,104 Underlying: Class A Common Stock · 79,104 shares Expires 2023-11-30 F6 · derivative.exercise_price: This option was granted on November 30, 2018 as an option for 70,000 shares of Class A Common Stock at an exercise price of $6.07 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019, and a 2 1/2% stock dividend paid on July 17, 2020. F6 · shares: This option was granted on November 30, 2018 as an option for 70,000 shares of Class A Common Stock at an exercise price of $6.07 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019, and a 2 1/2% stock dividend paid on July 17, 2020. F6 · price: This option was granted on November 30, 2018 as an option for 70,000 shares of Class A Common Stock at an exercise price of $6.07 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019, and a 2 1/2% stock dividend paid on July 17, 2020. F6 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option for 70,000 shares of Class A Common Stock at an exercise price of $6.07 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019, and a 2 1/2% stock dividend paid on July 17, 2020. F6 · balance_after: This option was granted on November 30, 2018 as an option for 70,000 shares of Class A Common Stock at an exercise price of $6.07 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019, and a 2 1/2% stock dividend paid on July 17, 2020. Read SEC document |
| November 30, 2018 Filed Jan 7, 2021 16:20 UTC |
Overbaugh Jason G.Director · VP/Ntnl Mkting Dir of Life Ins
|
GrantEmployee Stock Option (right to buy) · Derivative | 28,252 | $4.86 Strike: $4.86 | $137,304.72 |
DisclosureSEC source: 0001096906-21-000039 · form4.xml · derivative · entry 6 Overbaugh Jason G. · CIK 0001588310 · Director · VP/Ntnl Mkting Dir of Life Ins 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,252 Underlying: Class C Common Stock · 28,252 shares Expires 2028-11-30 F6 · derivative.exercise_price: This option was granted on November 30, 2018 as an option to purchase either 25,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution rights of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. F6 · shares: This option was granted on November 30, 2018 as an option to purchase either 25,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution rights of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. F6 · price: This option was granted on November 30, 2018 as an option to purchase either 25,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution rights of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. F6 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option to purchase either 25,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution rights of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. F6 · balance_after: This option was granted on November 30, 2018 as an option to purchase either 25,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution rights of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. Read SEC document |
| November 30, 2018 Filed Jan 11, 2021 22:14 UTC |
Sill Garrett S.CFO and Treasurer
|
GrantEmployee Stock Option (right to buy) · Derivative | 22,601 | $4.86 Strike: $4.86 | $109,840.86 |
DisclosureSEC source: 0001096906-21-000059 · form4.xml · derivative · entry 6 Sill Garrett S. · CIK 0001568673 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,601 Underlying: Class C Common Stock · 22,601 shares Expires 2028-11-30 F6 · derivative.exercise_price: This option was granted on November 30, 2018 as an option for either 20,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. F6 · shares: This option was granted on November 30, 2018 as an option for either 20,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. F6 · price: This option was granted on November 30, 2018 as an option for either 20,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. F6 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option for either 20,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. F6 · balance_after: This option was granted on November 30, 2018 as an option for either 20,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020. Read SEC document |
| November 30, 2018 Filed Jan 12, 2021 17:53 UTC |
MOODY H. CRAIGDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 1,131 | $4.86 Strike: $4.86 | $5,496.66 |
DisclosureSEC source: 0001096906-21-000064 · form4.xml · derivative · entry 16 MOODY H. CRAIG · CIK 0001298129 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,131 Underlying: Class A Common Stock · 1,131 shares Expires 2028-11-30 F15 · derivative.exercise_price: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F15 · shares: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F15 · price: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F15 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F15 · balance_after: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. Read SEC document |
| November 30, 2018 Filed Jan 12, 2021 17:53 UTC |
MOODY H. CRAIGDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 5,651 | $4.86 Strike: $4.86 | $27,463.86 |
DisclosureSEC source: 0001096906-21-000064 · form4.xml · derivative · entry 15 MOODY H. CRAIG · CIK 0001298129 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,651 Underlying: Class A Common Stock · 5,651 shares Expires 2028-11-30 F14 · derivative.exercise_price: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F14 · shares: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F14 · price: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F14 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F14 · balance_after: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. Read SEC document |
| November 30, 2018 Filed Jan 27, 2021 19:05 UTC |
MOODY H. CRAIGDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 1,131 | $4.86 Strike: $4.86 | $5,496.66 |
DisclosureSEC source: 0001096906-21-000154 · form4.xml · derivative · entry 17 MOODY H. CRAIG · CIK 0001298129 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,131 Underlying: Class A Common Stock · 1,131 shares Expires 2028-11-30 F15 · derivative.exercise_price: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F15 · shares: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F15 · price: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F15 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F15 · balance_after: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. Read SEC document |
| November 30, 2018 Filed Jan 27, 2021 19:05 UTC |
MOODY H. CRAIGDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 5,651 | $4.86 Strike: $4.86 | $27,463.86 |
DisclosureSEC source: 0001096906-21-000154 · form4.xml · derivative · entry 16 MOODY H. CRAIG · CIK 0001298129 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,651 Underlying: Class A Common Stock · 5,651 shares Expires 2028-11-30 F14 · derivative.exercise_price: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F14 · shares: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F14 · price: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F14 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F14 · balance_after: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. Read SEC document |
| November 30, 2018 Filed Jan 29, 2021 23:47 UTC |
Wilbur Norman GDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 1,131 | $4.86 Strike: $4.86 | $5,496.66 |
DisclosureSEC source: 0001096906-21-000198 · form4.xml · derivative · entry 11 Wilbur Norman G · CIK 0001298096 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,131 Underlying: Class A Common Stock · 1,131 shares Expires 2028-11-30 F8 · derivative.exercise_price: This option was granted on November 30, 2018 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F8 · shares: This option was granted on November 30, 2018 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F8 · price: This option was granted on November 30, 2018 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F8 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F8 · balance_after: This option was granted on November 30, 2018 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. Read SEC document |
| November 30, 2018 Filed Jan 29, 2021 23:47 UTC |
Wilbur Norman GDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 5,651 | $4.86 Strike: $4.86 | $27,463.86 |
DisclosureSEC source: 0001096906-21-000198 · form4.xml · derivative · entry 10 Wilbur Norman G · CIK 0001298096 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,651 Underlying: Class A Common Stock · 5,651 shares Expires 2028-11-30 F7 · derivative.exercise_price: This option was granted on November 30, 2018 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F7 · shares: This option was granted on November 30, 2018 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F7 · price: This option was granted on November 30, 2018 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F7 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F7 · balance_after: This option was granted on November 30, 2018 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. Read SEC document |
| November 30, 2018 Filed Feb 2, 2021 23:56 UTC |
Wilbur Norman GDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 1,131 | $4.86 Strike: $4.86 | $5,496.66 |
DisclosureSEC source: 0001096906-21-000226 · form4.xml · derivative · entry 8 Wilbur Norman G · CIK 0001298096 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,131 Underlying: Class A Common Stock · 1,131 shares Expires 2028-11-30 F6 · derivative.exercise_price: This option was granted on November 30, 2018 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F6 · shares: This option was granted on November 30, 2018 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F6 · price: This option was granted on November 30, 2018 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F6 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F6 · balance_after: This option was granted on November 30, 2018 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. Read SEC document |
| November 30, 2018 Filed Feb 2, 2021 23:56 UTC |
Wilbur Norman GDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 5,651 | $4.86 Strike: $4.86 | $27,463.86 |
DisclosureSEC source: 0001096906-21-000226 · form4.xml · derivative · entry 7 Wilbur Norman G · CIK 0001298096 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,651 Underlying: Class A Common Stock · 5,651 shares Expires 2028-11-30 F5 · derivative.exercise_price: This option was granted on November 30, 2018 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F5 · shares: This option was granted on November 30, 2018 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F5 · price: This option was granted on November 30, 2018 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F5 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F5 · balance_after: This option was granted on November 30, 2018 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. Read SEC document |
| November 30, 2018 Filed Feb 2, 2021 23:40 UTC Amendment |
Wilbur Norman GDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 1,131 | $4.86 Strike: $4.86 | $5,496.66 |
DisclosureSEC source: 0001096906-21-000224 · form4.xml · derivative · entry 11 Wilbur Norman G · CIK 0001298096 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,131 Underlying: Class A Common Stock · 1,131 shares Expires 2028-11-30 F8 · derivative.exercise_price: This option was granted on November 30, 2018 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F8 · shares: This option was granted on November 30, 2018 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F8 · price: This option was granted on November 30, 2018 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F8 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F8 · balance_after: This option was granted on November 30, 2018 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. Read SEC document |
| November 30, 2018 Filed Feb 2, 2021 23:40 UTC Amendment |
Wilbur Norman GDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 5,651 | $4.86 Strike: $4.86 | $27,463.86 |
DisclosureSEC source: 0001096906-21-000224 · form4.xml · derivative · entry 10 Wilbur Norman G · CIK 0001298096 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,651 Underlying: Class A Common Stock · 5,651 shares Expires 2028-11-30 F7 · derivative.exercise_price: This option was granted on November 30, 2018 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F7 · shares: This option was granted on November 30, 2018 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F7 · price: This option was granted on November 30, 2018 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F7 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F7 · balance_after: This option was granted on November 30, 2018 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. Read SEC document |
| November 30, 2018 Filed Apr 23, 2021 23:55 UTC |
MOODY H. CRAIGDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 1,131 | $4.86 Strike: $4.86 | $5,496.66 |
DisclosureSEC source: 0001096906-21-000852 · primary_doc.xml · derivative · entry 17 MOODY H. CRAIG · CIK 0001298129 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,131 Underlying: Class A Common Stock · 1,131 shares Expires 2028-11-30 F15 · derivative.exercise_price: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F15 · shares: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F15 · price: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F15 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F15 · balance_after: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. Read SEC document |
| November 30, 2018 Filed Apr 23, 2021 23:55 UTC |
MOODY H. CRAIGDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 5,651 | $4.86 Strike: $4.86 | $27,463.86 |
DisclosureSEC source: 0001096906-21-000852 · primary_doc.xml · derivative · entry 16 MOODY H. CRAIG · CIK 0001298129 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,651 Underlying: Class A Common Stock · 5,651 shares Expires 2028-11-30 F14 · derivative.exercise_price: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F14 · shares: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F14 · price: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F14 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. F14 · balance_after: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020. Read SEC document |
| November 30, 2018 Filed Aug 17, 2021 19:39 UTC |
Stephens Jeffrey RussellSr Gen Counsel/Corp Secretary
|
GrantEmployee Stock Option (right to buy) · Derivative | 8,476 | $4.86 Strike: $4.86 | $41,193.36 |
DisclosureSEC source: 0001096906-21-002068 · primary_doc.xml · derivative · entry 11 Stephens Jeffrey Russell · CIK 0001488171 · Sr Gen Counsel/Corp Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,476 Underlying: Class A Common Stock · 8,476 shares Expires 2028-11-30 F10 · derivative.exercise_price: This option was granted on November 30, 2018 as an option for 7,500 shares of Class A Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilutions provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021. F10 · shares: This option was granted on November 30, 2018 as an option for 7,500 shares of Class A Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilutions provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021. F10 · price: This option was granted on November 30, 2018 as an option for 7,500 shares of Class A Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilutions provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021. F10 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option for 7,500 shares of Class A Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilutions provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021. F10 · balance_after: This option was granted on November 30, 2018 as an option for 7,500 shares of Class A Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilutions provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021. Read SEC document |
| November 30, 2018 Filed Aug 25, 2021 22:49 UTC |
Overbaugh Jason G.Director · VP/Ntnl Marketing Dir-Life Ins
|
GrantEmployee Stock Option (right to buy) · Derivative | 28,252 | $4.86 Strike: $4.86 | $137,304.72 |
DisclosureSEC source: 0001096906-21-002161 · primary_doc.xml · derivative · entry 5 Overbaugh Jason G. · CIK 0001588310 · Director · VP/Ntnl Marketing Dir-Life Ins 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,252 Underlying: Class C Common Stock · 28,252 shares Expires 2028-11-30 F5 · derivative.exercise_price: This option was granted on November 30, 2018 as an option to purchase either 25,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution rights of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021. F5 · shares: This option was granted on November 30, 2018 as an option to purchase either 25,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution rights of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021. F5 · price: This option was granted on November 30, 2018 as an option to purchase either 25,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution rights of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021. F5 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option to purchase either 25,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution rights of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021. F5 · balance_after: This option was granted on November 30, 2018 as an option to purchase either 25,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution rights of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021. Read SEC document |
| November 30, 2018 Filed Aug 25, 2021 22:03 UTC |
Overbaugh Jason G.Director · VP/Ntnl Marketing Dir-Life Ins
|
GrantEmployee Stock Option (right to buy) · Derivative | 28,252 | $4.86 Strike: $4.86 | $137,304.72 |
DisclosureSEC source: 0001096906-21-002160 · primary_doc.xml · derivative · entry 8 Overbaugh Jason G. · CIK 0001588310 · Director · VP/Ntnl Marketing Dir-Life Ins 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,252 Underlying: Class C Common Stock · 28,252 shares Expires 2028-11-30 F7 · derivative.exercise_price: This option was granted on November 30, 2018 as an option to purchase either 25,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution rights of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021. F7 · shares: This option was granted on November 30, 2018 as an option to purchase either 25,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution rights of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021. F7 · price: This option was granted on November 30, 2018 as an option to purchase either 25,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution rights of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021. F7 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option to purchase either 25,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution rights of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021. F7 · balance_after: This option was granted on November 30, 2018 as an option to purchase either 25,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution rights of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021. Read SEC document |
| November 30, 2018 Filed Sep 15, 2021 21:58 UTC |
Quist Adam GeorgeDirector · Vice President/General Counsel
|
GrantEmployee Stock Option (right to buy) · Derivative | Not disclosed | $4.86 Strike: $4.86 | $22,601.00 |
DisclosureSEC source: 0001096906-21-002274 · ownership.xml · derivative · entry 8 Quist Adam George · CIK 0001740330 · Director · Vice President/General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: Not disclosed Underlying: Class A Common Stock · Not disclosed shares Expires 2028-11-30 F7 · derivative.exercise_price: This option was granted on November 30, 2018 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; a 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. F7 · reported_value: This option was granted on November 30, 2018 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; a 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. F7 · price: This option was granted on November 30, 2018 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; a 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. F7 · underlyingValue: This option was granted on November 30, 2018 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; a 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. F7 · valueOwnedAfter: This option was granted on November 30, 2018 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; a 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. Read SEC document |
| November 30, 2018 Filed Oct 14, 2021 18:14 UTC |
Cook John LDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 1,188 | $4.74 Strike: $4.74 | $5,631.12 |
DisclosureSEC source: 0001493152-21-025402 · ownership.xml · derivative · entry 11 Cook John L · CIK 0001593993 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,188 Underlying: Class A Common Stock · 1,188 shares Expires 2028-11-30 F11 · derivative.exercise_price: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; a 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. F11 · shares: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; a 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. F11 · price: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; a 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. F11 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; a 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. F11 · balance_after: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; a 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. Read SEC document |
| November 30, 2018 Filed Oct 14, 2021 18:14 UTC |
Cook John LDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 5,935 | $4.74 Strike: $4.74 | $28,131.90 |
DisclosureSEC source: 0001493152-21-025402 · ownership.xml · derivative · entry 10 Cook John L · CIK 0001593993 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,935 Underlying: Class A Common Stock · 5,935 shares Expires 2028-11-30 F10 · derivative.exercise_price: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; a 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. F10 · shares: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; a 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. F10 · price: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; a 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. F10 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; a 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. F10 · balance_after: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; a 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. Read SEC document |
| November 30, 2018 Filed Oct 14, 2021 18:10 UTC |
FULLER GILBERT ADirector
|
GrantDirector Stock Option (right to buy) · Derivative | 1,188 | $4.74 Strike: $4.74 | $5,631.12 |
DisclosureSEC source: 0001493152-21-025400 · ownership.xml · derivative · entry 12 FULLER GILBERT A · CIK 0001203302 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,188 Underlying: Class A Common Stock · 1,188 shares Expires 2028-01-30 F12 · derivative.exercise_price: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; a 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. F12 · shares: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; a 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. F12 · price: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; a 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. F12 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; a 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. F12 · balance_after: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; a 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. Read SEC document |
| November 30, 2018 Filed Oct 14, 2021 18:10 UTC |
FULLER GILBERT ADirector
|
GrantDirector Stock Option (right to buy) · Derivative | 5,935 | $4.74 Strike: $4.74 | $28,131.90 |
DisclosureSEC source: 0001493152-21-025400 · ownership.xml · derivative · entry 11 FULLER GILBERT A · CIK 0001203302 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,935 Underlying: Class A Common Stock · 5,935 shares Expires 2028-11-30 F11 · derivative.exercise_price: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; a 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. F11 · shares: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; a 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. F11 · price: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; a 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. F11 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; a 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. F11 · balance_after: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; a 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. Read SEC document |
| November 30, 2018 Filed Oct 18, 2021 19:50 UTC |
Hunter Robert GailDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 1,188 | $4.74 Strike: $4.74 | $5,631.12 |
DisclosureSEC source: 0001493152-21-025687 · ownership.xml · derivative · entry 16 Hunter Robert Gail · CIK 0001298091 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,188 Underlying: Class A Common Stock · 1,188 shares Expires 2028-11-30 F16 · derivative.exercise_price: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock options paid on February 1, 2019, and February 7, 2020; a 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. F16 · shares: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock options paid on February 1, 2019, and February 7, 2020; a 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. F16 · price: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock options paid on February 1, 2019, and February 7, 2020; a 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. F16 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock options paid on February 1, 2019, and February 7, 2020; a 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. F16 · balance_after: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock options paid on February 1, 2019, and February 7, 2020; a 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. Read SEC document |
| November 30, 2018 Filed Oct 18, 2021 19:50 UTC |
Hunter Robert GailDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 5,935 | $4.74 Strike: $4.74 | $28,131.90 |
DisclosureSEC source: 0001493152-21-025687 · ownership.xml · derivative · entry 15 Hunter Robert Gail · CIK 0001298091 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,935 Underlying: Class A Common Stock · 5,935 shares Expires 2028-11-30 F15 · derivative.exercise_price: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock options paid on February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. F15 · shares: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock options paid on February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. F15 · price: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock options paid on February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. F15 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock options paid on February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. F15 · balance_after: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock options paid on February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. Read SEC document |
| November 30, 2018 Filed Oct 19, 2021 21:55 UTC |
MOODY H. CRAIGDirector
|
GrantDirector Stock Option(right to buy) · Derivative | 1,188 | $4.74 Strike: $4.74 | $5,631.12 |
DisclosureSEC source: 0001493152-21-025808 · ownership.xml · derivative · entry 14 MOODY H. CRAIG · CIK 0001298129 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,188 Underlying: Class A Common Stock · 1,188 shares Expires 2028-11-30 F14 · derivative.exercise_price: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; a 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. F14 · shares: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; a 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. F14 · price: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; a 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. F14 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; a 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. F14 · balance_after: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; a 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. Read SEC document |
| November 30, 2018 Filed Oct 19, 2021 21:55 UTC |
MOODY H. CRAIGDirector
|
GrantDirector Stock Option(right to buy) · Derivative | 5,935 | $4.74 Strike: $4.74 | $28,131.90 |
DisclosureSEC source: 0001493152-21-025808 · ownership.xml · derivative · entry 13 MOODY H. CRAIG · CIK 0001298129 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,935 Underlying: Class A Common Stock · 5,935 shares Expires 2028-11-30 F13 · derivative.exercise_price: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; a 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. F13 · shares: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; a 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. F13 · price: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; a 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. F13 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; a 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. F13 · balance_after: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; a 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. Read SEC document |
| November 30, 2018 Filed Oct 21, 2021 21:29 UTC |
Overbaugh Jason G.Director · VP/Ntnl Marketing Dir-Life Ins
|
GrantEmployee Stock Option (right to buy) · Derivative | 29,665 | $4.62 Strike: $4.62 | $137,052.30 |
DisclosureSEC source: 0001493152-21-026009 · ownership.xml · derivative · entry 4 Overbaugh Jason G. · CIK 0001588310 · Director · VP/Ntnl Marketing Dir-Life Ins 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,665 Underlying: Class C Common Stock · 29,665 shares Expires 2028-11-30 F4 · derivative.exercise_price: This option was granted on November 30, 2018 as an option to purchase either 25,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution rights of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021. F4 · shares: This option was granted on November 30, 2018 as an option to purchase either 25,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution rights of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021. F4 · price: This option was granted on November 30, 2018 as an option to purchase either 25,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution rights of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021. F4 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option to purchase either 25,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution rights of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021. F4 · balance_after: This option was granted on November 30, 2018 as an option to purchase either 25,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution rights of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021. Read SEC document |
| November 30, 2018 Filed Oct 21, 2021 21:28 UTC |
Quist Adam GeorgeDirector · VP and General Counsel
|
GrantEmployee Stock Option (right to buy) · Derivative | 23,731 | $4.62 Strike: $4.62 | $109,637.22 |
DisclosureSEC source: 0001493152-21-026005 · ownership.xml · derivative · entry 3 Quist Adam George · CIK 0001740330 · Director · VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,731 Underlying: Class A Common Stock · 23,731 shares Expires 2028-11-30 F3 · derivative.exercise_price: This option was granted on November 30, 2018 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; a 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. F3 · shares: This option was granted on November 30, 2018 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; a 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. F3 · price: This option was granted on November 30, 2018 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; a 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. F3 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; a 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. F3 · balance_after: This option was granted on November 30, 2018 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; a 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. Read SEC document |
| November 30, 2018 Filed Oct 25, 2021 22:42 UTC |
Quist S. AndrewDirector · VP and General Counsel
|
GrantEmployee Stock Option(right to buy) · Derivative | 29,665 | $4.62 Strike: $4.62 | $137,052.30 |
DisclosureSEC source: 0001493152-21-026276 · ownership.xml · derivative · entry 9 Quist S. Andrew · CIK 0001588309 · Director · VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,665 Underlying: Class C Common Stock · 29,665 shares Expires 2028-11-30 F9 · derivative.exercise_price: This option was granted on November 30, 2018 as an option for either 25,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. F9 · shares: This option was granted on November 30, 2018 as an option for either 25,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. F9 · price: This option was granted on November 30, 2018 as an option for either 25,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. F9 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option for either 25,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. F9 · balance_after: This option was granted on November 30, 2018 as an option for either 25,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. Read SEC document |
| November 30, 2018 Filed Oct 27, 2021 18:44 UTC |
Sill Garrett S.CFO and Treasurer
|
GrantEmployee Stock Option(right to buy) · Derivative | 23,731 | $4.62 Strike: $4.62 | $109,637.22 |
DisclosureSEC source: 0001493152-21-026515 · ownership.xml · derivative · entry 6 Sill Garrett S. · CIK 0001568673 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,731 Underlying: Class C Common Stock · 23,731 shares Expires 2028-11-30 F6 · derivative.exercise_price: This option was granted on November 30, 2018 as an option for either 20,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; a 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. F6 · shares: This option was granted on November 30, 2018 as an option for either 20,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; a 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. F6 · price: This option was granted on November 30, 2018 as an option for either 20,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; a 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. F6 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option for either 20,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; a 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. F6 · balance_after: This option was granted on November 30, 2018 as an option for either 20,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; a 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. Read SEC document |
| November 30, 2018 Filed Oct 27, 2021 18:48 UTC |
Stephens Jeffrey RussellSr General Counsel/Corp Sec
|
GrantEmployee Stock Option (right to buy) · Derivative | 8,900 | $4.62 Strike: $4.62 | $41,118.00 |
DisclosureSEC source: 0001493152-21-026516 · ownership.xml · derivative · entry 6 Stephens Jeffrey Russell · CIK 0001488171 · Sr General Counsel/Corp Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: Not disclosed Underlying: Class A Common Stock · 8,900 shares Expires 2028-11-30 F6 · derivative.exercise_price: This option was granted on November 30, 2018 as an option for 7,500 shares of Class A Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilutions provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021. F6 · shares: This option was granted on November 30, 2018 as an option for 7,500 shares of Class A Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilutions provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021. F6 · price: This option was granted on November 30, 2018 as an option for 7,500 shares of Class A Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilutions provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021. F6 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option for 7,500 shares of Class A Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilutions provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021. F6 · valueOwnedAfter: This option was granted on November 30, 2018 as an option for 7,500 shares of Class A Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilutions provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021. Read SEC document |
| November 30, 2018 Filed Dec 8, 2021 15:41 UTC |
Hunter Robert GailDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 1,188 | $4.74 Strike: $4.74 | $5,631.12 |
DisclosureSEC source: 0001493152-21-030794 · ownership.xml · derivative · entry 16 Hunter Robert Gail · CIK 0001298091 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,188 Underlying: Class A Common Stock · 1,188 shares Expires 2028-11-30 F15 · derivative.exercise_price: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock options paid on February 1, 2019 and February 7, 2020; a 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. F15 · shares: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock options paid on February 1, 2019 and February 7, 2020; a 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. F15 · price: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock options paid on February 1, 2019 and February 7, 2020; a 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. F15 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock options paid on February 1, 2019 and February 7, 2020; a 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. F15 · balance_after: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock options paid on February 1, 2019 and February 7, 2020; a 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. Read SEC document |
| November 30, 2018 Filed Dec 8, 2021 15:41 UTC |
Hunter Robert GailDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 5,935 | $4.74 Strike: $4.74 | $28,131.90 |
DisclosureSEC source: 0001493152-21-030794 · ownership.xml · derivative · entry 15 Hunter Robert Gail · CIK 0001298091 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,935 Underlying: Class A Common Stock · 5,935 shares Expires 2028-11-30 F14 · derivative.exercise_price: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock options paid on February 1, 2019 and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. F14 · shares: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock options paid on February 1, 2019 and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. F14 · price: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock options paid on February 1, 2019 and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. F14 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock options paid on February 1, 2019 and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. F14 · balance_after: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock options paid on February 1, 2019 and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. Read SEC document |
| November 30, 2018 Filed Dec 22, 2021 22:52 UTC |
Stephens Jeffrey RussellSr General Counsel/Corp Sec
|
GrantEmployee Stock Option (right to buy) · Derivative | 8,900 | $4.62 Strike: $4.62 | $41,118.00 |
DisclosureSEC source: 0001493152-21-032307 · ownership.xml · derivative · entry 7 Stephens Jeffrey Russell · CIK 0001488171 · Sr General Counsel/Corp Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,900 Underlying: Class A Common Stock · 8,900 shares Expires 2028-11-30 F7 · derivative.exercise_price: This option was granted on November 30, 2018 as an option for 7,500 shares of Class A Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilutions provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021. F7 · shares: This option was granted on November 30, 2018 as an option for 7,500 shares of Class A Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilutions provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021. F7 · price: This option was granted on November 30, 2018 as an option for 7,500 shares of Class A Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilutions provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021. F7 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option for 7,500 shares of Class A Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilutions provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021. F7 · balance_after: This option was granted on November 30, 2018 as an option for 7,500 shares of Class A Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilutions provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021. Read SEC document |
| November 30, 2018 Filed Dec 31, 2021 00:40 UTC |
Quist Adam GeorgeDirector · VP and General Counsel
|
GrantEmployee Stock Option (right to buy) · Derivative | 23,731 | $4.62 Strike: $4.62 | $109,637.22 |
DisclosureSEC source: 0001493152-21-032916 · ownership.xml · derivative · entry 4 Quist Adam George · CIK 0001740330 · Director · VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,731 Underlying: Class A Common Stock · 23,731 shares Expires 2028-11-30 F4 · derivative.exercise_price: This option was granted on November 30, 2018 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; a 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. F4 · shares: This option was granted on November 30, 2018 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; a 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. F4 · price: This option was granted on November 30, 2018 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; a 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. F4 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; a 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. F4 · balance_after: This option was granted on November 30, 2018 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; a 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. Read SEC document |
| November 30, 2018 Filed Jan 24, 2022 19:15 UTC |
Quist S. AndrewDirector · VP and General Counsel
|
GrantEmployee Stock Option(right to buy) · Derivative | 29,665 | $4.62 Strike: $4.62 | $137,052.30 |
DisclosureSEC source: 0001493152-22-002081 · ownership.xml · derivative · entry 10 Quist S. Andrew · CIK 0001588309 · Director · VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,665 Underlying: Class C Common Stock · 29,665 shares Expires 2028-11-30 F8 · derivative.exercise_price: This option was granted on November 30, 2018 as an option for either 25,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. F8 · shares: This option was granted on November 30, 2018 as an option for either 25,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. F8 · price: This option was granted on November 30, 2018 as an option for either 25,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. F8 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option for either 25,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. F8 · balance_after: This option was granted on November 30, 2018 as an option for either 25,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. Read SEC document |
| November 30, 2018 Filed Jan 28, 2022 22:24 UTC |
Cook John LDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 7,123 | $4.74 Strike: $4.74 | $33,763.02 |
DisclosureSEC source: 0001493152-22-002594 · ownership.xml · derivative · entry 10 Cook John L · CIK 0001593993 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,123 Underlying: Class A Common Stock · 7,123 shares Expires 2028-11-30 F10 · derivative.exercise_price: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; a 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. F10 · shares: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; a 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. F10 · price: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; a 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. F10 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; a 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. F10 · balance_after: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; a 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. Read SEC document |
| November 30, 2018 Filed Jan 28, 2022 21:43 UTC |
FULLER GILBERT ADirector
|
GrantDirector Stock Option (right to buy) · Derivative | 7,123 | $4.74 Strike: $4.74 | $33,763.02 |
DisclosureSEC source: 0001493152-22-002561 · ownership.xml · derivative · entry 10 FULLER GILBERT A · CIK 0001203302 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,123 Underlying: Class A Common Stock · 7,123 shares Expires 2028-01-30 F10 · derivative.exercise_price: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; a 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. F10 · shares: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; a 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. F10 · price: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; a 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. F10 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; a 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. F10 · balance_after: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; a 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. Read SEC document |
| November 30, 2018 Filed Feb 4, 2022 00:55 UTC |
QUIST SCOTT MDirector · Board Chair, Pres, CEO · 10% owner
|
GrantEmployee Stock Option (right to buy) · Derivative | 83,059 | $5.07 Strike: $5.07 | $421,109.13 |
DisclosureSEC source: 0001493152-22-003143 · ownership.xml · derivative · entry 9 QUIST SCOTT M · CIK 0001268844 · Director · Board Chair, Pres, CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,059 Underlying: Class A Common Stock · 83,059 shares Expires 2023-11-30 F5 · derivative.exercise_price: This option was granted on November 30, 2018 as an option for 70,000 shares of Class A Common Stock at an exercise price of $6.07 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021. F5 · shares: This option was granted on November 30, 2018 as an option for 70,000 shares of Class A Common Stock at an exercise price of $6.07 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021. F5 · price: This option was granted on November 30, 2018 as an option for 70,000 shares of Class A Common Stock at an exercise price of $6.07 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021. F5 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option for 70,000 shares of Class A Common Stock at an exercise price of $6.07 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021. F5 · balance_after: This option was granted on November 30, 2018 as an option for 70,000 shares of Class A Common Stock at an exercise price of $6.07 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021. Read SEC document |
| November 30, 2018 Filed Feb 4, 2022 22:51 UTC |
Overbaugh Jason G.Director · VP & Nat'l Marketing Dir/Life
|
GrantEmployee Stock Option(right to buy) · Derivative | 28,252 | $4.86 Strike: $4.86 | $137,304.72 |
DisclosureSEC source: 0001493152-22-003299 · ownership.xml · derivative · entry 5 Overbaugh Jason G. · CIK 0001588310 · Director · VP & Nat'l Marketing Dir/Life 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,252 Underlying: Class C Common Stock · 28,252 shares Expires 2028-11-30 F5 · derivative.exercise_price: This option was granted on November 30, 2018 as an option to purchase either 25,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution rights of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021. F5 · shares: This option was granted on November 30, 2018 as an option to purchase either 25,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution rights of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021. F5 · price: This option was granted on November 30, 2018 as an option to purchase either 25,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution rights of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021. F5 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option to purchase either 25,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution rights of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021. F5 · balance_after: This option was granted on November 30, 2018 as an option to purchase either 25,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution rights of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021. Read SEC document |
| November 30, 2018 Filed Feb 7, 2022 23:16 UTC |
Hunter Robert GailDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 7,123 | $4.74 Strike: $4.74 | $33,763.02 |
DisclosureSEC source: 0001493152-22-003388 · ownership.xml · derivative · entry 12 Hunter Robert Gail · CIK 0001298091 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,123 Underlying: Class A Common Stock · 7,123 shares Expires 2028-11-30 F12 · derivative.exercise_price: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock options paid on February 1, 2019 and February 7, 2020; a 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. F12 · shares: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock options paid on February 1, 2019 and February 7, 2020; a 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. F12 · price: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock options paid on February 1, 2019 and February 7, 2020; a 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. F12 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock options paid on February 1, 2019 and February 7, 2020; a 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. F12 · balance_after: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock options paid on February 1, 2019 and February 7, 2020; a 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. Read SEC document |
| November 30, 2018 Filed Feb 7, 2022 21:54 UTC |
Sill Garrett S.CFO and Treasurer
|
GrantEmployee Stock Option(right to buy) · Derivative | 23,731 | $4.62 Strike: $4.62 | $109,637.22 |
DisclosureSEC source: 0001493152-22-003373 · ownership.xml · derivative · entry 6 Sill Garrett S. · CIK 0001568673 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,731 Underlying: Class C Common Stock · 23,731 shares Expires 2028-11-30 F6 · derivative.exercise_price: This option was granted on November 30, 2018 as an option for either 20,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; a 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. F6 · shares: This option was granted on November 30, 2018 as an option for either 20,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; a 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. F6 · price: This option was granted on November 30, 2018 as an option for either 20,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; a 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. F6 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option for either 20,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; a 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. F6 · balance_after: This option was granted on November 30, 2018 as an option for either 20,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; a 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. Read SEC document |
| November 30, 2018 Filed Feb 10, 2022 20:43 UTC |
MOODY H. CRAIGDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 7,123 | $4.74 Strike: $4.74 | $33,763.02 |
DisclosureSEC source: 0001493152-22-003739 · ownership.xml · derivative · entry 12 MOODY H. CRAIG · CIK 0001298129 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,123 Underlying: Class A Common Stock · 7,123 shares Expires 2028-11-30 F12 · derivative.exercise_price: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; a 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. F12 · shares: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; a 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. F12 · price: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; a 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. F12 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; a 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. F12 · balance_after: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; a 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. Read SEC document |
| November 30, 2018 Filed Feb 10, 2022 20:27 UTC |
Stephens Jeffrey RussellSr General Counsel/Corp Sec
|
GrantEmployee Stock Option (right to buy) · Derivative | 8,900 | $4.62 Strike: $4.62 | $41,118.00 |
DisclosureSEC source: 0001493152-22-003737 · ownership.xml · derivative · entry 6 Stephens Jeffrey Russell · CIK 0001488171 · Sr General Counsel/Corp Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,900 Underlying: Class A Common Stock · 8,900 shares Expires 2028-11-30 F6 · derivative.exercise_price: This option was granted on November 30, 2018 as an option for 7,500 shares of Class A Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilutions provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021. F6 · shares: This option was granted on November 30, 2018 as an option for 7,500 shares of Class A Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilutions provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021. F6 · price: This option was granted on November 30, 2018 as an option for 7,500 shares of Class A Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilutions provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021. F6 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option for 7,500 shares of Class A Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilutions provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021. F6 · balance_after: This option was granted on November 30, 2018 as an option for 7,500 shares of Class A Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilutions provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021. Read SEC document |
| November 30, 2018 Filed Feb 15, 2022 18:14 UTC |
Quist Adam GeorgeDirector · VP and General Counsel
|
GrantEmployee Stock Option (right to buy) · Derivative | 23,731 | $4.62 Strike: $4.62 | $109,637.22 |
DisclosureSEC source: 0001493152-22-004653 · ownership.xml · derivative · entry 3 Quist Adam George · CIK 0001740330 · Director · VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,731 Underlying: Class C Common Stock · 23,731 shares Expires 2028-11-30 F3 · derivative.exercise_price: This option was granted on November 30, 2018 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; a 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. F3 · shares: This option was granted on November 30, 2018 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; a 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. F3 · price: This option was granted on November 30, 2018 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; a 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. F3 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; a 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. F3 · balance_after: This option was granted on November 30, 2018 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; a 2 1/2% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. Read SEC document |
| November 30, 2018 Filed Feb 16, 2022 18:23 UTC |
Quist S. AndrewDirector · Vice President/General Counsel
|
GrantEmployee Stock Option (right to buy) · Derivative | 29,665 | $4.62 Strike: $4.62 | $137,052.30 |
DisclosureSEC source: 0001096906-22-000345 · form4.xml · derivative · entry 9 Quist S. Andrew · CIK 0001588309 · Director · Vice President/General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,665 Underlying: Class C Common Stock · 29,665 shares Expires 2028-11-30 F9 · derivative.exercise_price: This option was granted on November 30, 2018 as an option for either 25,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; and a 2.5% stock dividend paid on July 17, 2020; and a 5% stock dividend paid on July 16, 2021. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.